U.S. Physical Therapy (NYSE:USPH) Reaches New 52-Week High - Should You Buy?

Key Points

• U.S. Physical Therapy hit a 52-week high, reaching $101.80 intraday before last trading at $99.06.
• Analysts’ consensus rating is “Moderate Buy”, with an average price target of $101.25; Barrington Research raised its target to $110.
• Quarterly results beat estimates: EPS was $0.80 versus $0.76 expected, while revenue rose 12.9% year over year to $222.56 million. The company also declared a $0.46 quarterly dividend.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday. The stock traded as high as $101.80 and last traded at $99.0550, with a volume of 12,333 shares changing hands. The stock had previously closed at $100.10.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a research report on Friday, September 11th. Citigroup reissued a "market outperform" rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Barrington Research boosted their target price on shares of U.S. Physical Therapy from $98.00 to $110.00 and gave the stock an "outperform" rating in a research report on Friday, November 6th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, U.S. Physical Therapy presently has an average rating of "Moderate Buy" and an average price target of $101.25.

U.S. Physical Therapy Trading Down 1.4%

The stock has a 50-day simple moving average of $85.50 and a 200 day simple moving average of $77.25. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.56. The company has a market cap of $1.47 billion, a price-to-earnings ratio of -73.23, a PEG ratio of 2.72 and a beta of 1.16.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.76 by $0.04. U.S. Physical Therapy had a return on equity of 10.19% and a net margin of 3.60%. The business had revenue of $222.56 million for the quarter, compared to the consensus estimate of $214.48 million. During the same quarter in the previous year, the business earned $0.66 EPS. The company's quarterly revenue was up 12.9% compared to the same quarter last year. As a group, equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.87 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 11th. Shareholders of record on Monday, November 16th will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.84 dividend on an annualized basis and a yield of 1.9%. U.S. Physical Therapy's dividend payout ratio (DPR) is currently -136.30%.

Institutional Trading of U.S. Physical Therapy

Several large investors have recently made changes to their positions in the business. BlackRock Inc. purchased a new position in shares of U.S. Physical Therapy during the second quarter worth $155,505,000. Copeland Capital Management LLC boosted its holdings in U.S. Physical Therapy by 11.8% in the third quarter. Copeland Capital Management LLC now owns 940,528 shares of the company's stock valued at $80,632,000 after purchasing an additional 98,984 shares during the last quarter. Bahl & Gaynor LLC grew its position in U.S. Physical Therapy by 3.2% during the 3rd quarter. Bahl & Gaynor LLC now owns 889,265 shares of the company's stock worth $76,237,000 after purchasing an additional 27,691 shares during the period. William Blair Investment Management LLC grew its position in U.S. Physical Therapy by 50.9% during the 3rd quarter. William Blair Investment Management LLC now owns 659,509 shares of the company's stock worth $56,540,000 after purchasing an additional 222,513 shares during the period. Finally, Bank of America Corp DE grew its position in U.S. Physical Therapy by 10.9% during the 1st quarter. Bank of America Corp DE now owns 554,621 shares of the company's stock worth $41,574,000 after purchasing an additional 54,656 shares during the period.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics across the United States. Its clinics provide rehabilitation for musculoskeletal conditions, orthopedic injuries, sports-related injuries and recovery following surgery, along with other therapy services tailored to patients' needs. Founded in 1990 and headquartered in Houston, Texas, the company also provides industrial injury prevention and related services to employers. Its clinic network serves communities in multiple states, with care delivered through local therapy practices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.